By Kevin Madigan & Sean O’Connor This week, the Senate Judiciary Committee was to mark up a bill limiting patent eligibility for combination drug patents—new forms, uses, and administrations of […]
[Archived Post] Law Professors & Economists Urge Caution on VENUE Act in Letter to Congress
Today, 28 law professors, economists, and political scientists from across the nation submitted a letter to Congress expressing serious concerns about the recent push for sweeping changes to patent litigation […]
[Archived Post] Federal Circuit Brings Some Clarity and Sanity Back to Patent Eligibility Doctrine
By Adam Mossoff and Kevin Madigan Following the Supreme Court’s four decisions on patent eligibility for inventions under § 101 of the Patent Act, there has been much disruption and […]
[Archived Post] Do As I Say, Not As I Do: Google’s Patent Transparency Hypocrisy
It is common today to hear that it’s simply impossible to search a field of technology to determine whether patents are valid or if there’s even freedom to operate at […]
[Archived Post] Acknowledging the Limitations of the FTC’s PAE Study
The FTC’s long-awaited case study of patent assertion entities (PAEs) is expected to be released this spring. Using its subpoena power under Section 6(b) to gather information from a handful […]
[Archived Post] Changes to Patent Venue Rules Risk Collateral Damage to Innovators
By Devlin Hartline Advocates for changing the patent venue rules, which dictate where patent owners can sue alleged infringers, have been arguing that their remedy will cure the supposed disease […]
[Archived Post] No Consensus That Broad Patent ‘Reform’ is Necessary or Helpful
Here’s a brief excerpt of an op-ed by Adam Mossoff & Devlin Hartline that was published in The Hill: Two recent op-eds published in The Hill argue that broad patent […]
[Archived Post] How Patents Help Startups Grow, Innovate, and Succeed
By Devlin Hartline Many academic studies of the patent system focus on the negative, extrapolating from anecdotes about a few bad actors to make the case that our patent system […]
